MX2020010159A - Composiciones de creatina y/o creatinina y metodos relacionados. - Google Patents

Composiciones de creatina y/o creatinina y metodos relacionados.

Info

Publication number
MX2020010159A
MX2020010159A MX2020010159A MX2020010159A MX2020010159A MX 2020010159 A MX2020010159 A MX 2020010159A MX 2020010159 A MX2020010159 A MX 2020010159A MX 2020010159 A MX2020010159 A MX 2020010159A MX 2020010159 A MX2020010159 A MX 2020010159A
Authority
MX
Mexico
Prior art keywords
compositions
creatinine
creatine
related methods
methods
Prior art date
Application number
MX2020010159A
Other languages
English (en)
Inventor
Alexandros Nikolaidis
Ronald Kramer
Original Assignee
Thermolife Int Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thermolife Int Llc filed Critical Thermolife Int Llc
Publication of MX2020010159A publication Critical patent/MX2020010159A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Polymers & Plastics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Food Science & Technology (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Dermatology (AREA)

Abstract

La descripción se dirige a composiciones de creatina estables que comprenden creatinina, composiciones que comprenden creatinina, y métodos para utilizar tales composiciones.
MX2020010159A 2018-03-27 2019-03-27 Composiciones de creatina y/o creatinina y metodos relacionados. MX2020010159A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201862648870P 2018-03-27 2018-03-27
US201862650594P 2018-03-30 2018-03-30
US16/367,209 US20190298667A1 (en) 2018-03-27 2019-03-27 Creatine and/or creatinine compositions and related methods
PCT/US2019/024440 WO2019191338A1 (en) 2018-03-27 2019-03-27 Creatine and/or creatinine compositions and related methods

Publications (1)

Publication Number Publication Date
MX2020010159A true MX2020010159A (es) 2021-02-26

Family

ID=68057556

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020010159A MX2020010159A (es) 2018-03-27 2019-03-27 Composiciones de creatina y/o creatinina y metodos relacionados.

Country Status (5)

Country Link
US (2) US20190298667A1 (es)
CA (1) CA3095440A1 (es)
MX (1) MX2020010159A (es)
WO (1) WO2019191338A1 (es)
ZA (1) ZA202006579B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11154499B2 (en) * 2018-03-27 2021-10-26 Thermolife International, Llc Creatine and/or creatinine compositions and related methods

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6524611B2 (en) * 1996-05-31 2003-02-25 The Howard Foundation Compositions containing creatine and creatinine
US10435356B1 (en) * 2007-09-18 2019-10-08 Thermolife International, Llc Amino acid compositions
JP6882191B2 (ja) * 2015-04-20 2021-06-02 ビレオ システムズ インコーポレイテッド 神経保護および神経変性の治療のための組成物および方法
US11154499B2 (en) * 2018-03-27 2021-10-26 Thermolife International, Llc Creatine and/or creatinine compositions and related methods
WO2020264412A1 (en) * 2019-06-28 2020-12-30 Thermolife International, Llc Compositions for creatine supplementation in creatine non-responders

Also Published As

Publication number Publication date
CA3095440A1 (en) 2019-10-03
US20190298667A1 (en) 2019-10-03
US20230062170A1 (en) 2023-03-02
ZA202006579B (en) 2021-09-29
WO2019191338A1 (en) 2019-10-03

Similar Documents

Publication Publication Date Title
MX2020006812A (es) Degradadores de cinasas asociadas al receptor de interleucina-1 (irak) y usos de los mismos.
MX2021006154A (es) Degradadores de cinasas asociadas al receptor de interleucina 1 (irak) y usos de los mismos.
ZA201906822B (en) Indole ahr inhibitors and uses thereof
MX2018005292A (es) Inhibidores de acc y usos de los mismos.
MX2020007799A (es) Inhibidores de cinasa no derrepresible de control de aminoacido general 2 (gcn2) y sus usos.
TN2018000276A1 (en) Inhibitors of receptor-interacting protein kinase 1.
MX2019011496A (es) Composiciones de niraparib.
MX2018009773A (es) Heteroarilos inhibidores de peptidilarginina desiminasa 4 (pad4).
MX2018016038A (es) Compuestos y metodos para modular la funcion del acido ribonucleico (arn).
EA201691916A1 (ru) Биарильные ингибиторы киназы
MX2022000053A (es) Moduladores de interaccion de sestrina-gator2 y sus usos.
AU2017317563A8 (en) Detergent compositions comprising xanthan lyase variants I
PH12018502137A1 (en) Anti-complement factor bb antibodies and uses thereof
MX2020001793A (es) Inhibidores del receptor de hidrocarburos de arilo (ahr) y usos de los mismos.
MX2019005322A (es) Composiciones de recubrimiento y metodos de uso de las mismas.
MX2018006700A (es) Inhibidores aza-bencimidazol de peptidilarginina desiminasa (pad4).
EP4234552A3 (en) 3-phosphoglycerate dehydrogenase inhibitors and uses thereof
MX2020006596A (es) Hidroxiisoxazolinas y derivados de estos.
MX2020007945A (es) Proteinas f del rsv estabilizadas y usos de las mismas.
PH12018502233A1 (en) ErbB INHIBITORS AND USES THEREOF
EA201892500A1 (ru) Применение фракции лигнина в качестве антифитопатогенного агента и содержащие ее антифитопатогенные композиции
MX2017008390A (es) Uretanos funcionalizados con alcoxisilano y funcionalizados con alofanato.
MX2022007841A (es) Degradadores del regulador dependiente de actina asociado a la matriz relacionado con el complejo switch/sacarosa no fermentable de la subfamilia a de la cromatina (smarca)y usos de los mismos.
MX2019009759A (es) Composiciones de peptido estables.
MX2018016037A (es) Variantes de lipasa y composiciones que comprenden tensioactivo y variante de lipasa.